Page last updated: 2024-10-17

aminocaproic acid and Bright Disease

aminocaproic acid has been researched along with Bright Disease in 4 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LAGRUE, G1
MILLIEZ, P1
Hruby, Z1
Wendycz, D1
Kopeć, W1
Czerchawski, L1
Józefowiak, M1
Rabczyński, J1
Nzerue, CM1
Falana, B1
Kuźniar, J1
Szewczyk, Z1

Reviews

2 reviews available for aminocaproic acid and Bright Disease

ArticleYear
[NEPHROLOGY IN 1964].
    La Revue du praticien, 1964, Jun-21, Volume: 14

    Topics: Acute Kidney Injury; Aminocaproates; Aminocaproic Acid; Antineoplastic Agents; Diabetes Mellitus; Di

1964
[Is local antiproteolytic failure the cause of a prolonged course in various forms of glomerulonephritis?].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1990, Jun-01, Volume: 43, Issue:11

    Topics: Aminocaproic Acid; Chronic Disease; Glomerulonephritis; Humans; Peptide Hydrolases; Protease Inhibit

1990

Other Studies

2 other studies available for aminocaproic acid and Bright Disease

ArticleYear
Effect of antiproteolytic drugs: epsilon-aminocaproic acid (EACA) and aprotinin on experimental anti-GBM nephritis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:1

    Topics: Aminocaproic Acid; Animals; Antifibrinolytic Agents; Aprotinin; Creatinine; Disease Models, Animal;

1996
Refractory hyperkalaemia associated with use of epsilon-aminocaproic acid during coronary bypass in a dialysis patient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:6

    Topics: Aminocaproic Acid; Calcium Gluconate; Cardiopulmonary Bypass; Coronary Artery Bypass; Electrocardiog

2002